JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst David Turkaly has reiterated a 'Market Outperform' rating on Steris (NYSE:STE) and maintained a price target of $265.
November 09, 2023 | 5:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Steris (NYSE:STE) has been reiterated with a 'Market Outperform' rating by JMP Securities, with a maintained price target of $265.
The reiteration of a 'Market Outperform' rating by JMP Securities indicates a positive outlook for Steris. The maintained price target of $265 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100